Efficacy of ceftobiprole medocaril against Enterococcus faecalis in a murine urinary tract infection model

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 6, 2012, Pages 3457-3460

  Singh, Kavindra V ^a   Murray, Barbara E ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; BACTERIAL ENZYME; BETA LACTAMASE; CEFTOBIPROLE MEDOCARIL; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BLADDER; COLONY FORMING UNIT; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFICACY; ENTEROCOCCUS FAECALIS; KIDNEY; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; URINARY TRACT INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; ENTEROCOCCUS FAECALIS; MICE; URINARY TRACT INFECTIONS;

EID: 84861162318     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.06102-11     Document Type: Article

References (35)

1. Arias CA, Singh KV, Panesso D, Murray BE. 2007. Evaluation of ceftobiprole medocaril against Enterococcus faecalis in a mouse peritonitis model. J. Antimicrob. Chemother. 60:594-598. (Pubitemid 47299874)
2. Arias CA, Singh KV, Panesso D, Murray BE. 2007. Time-kill and synergism studies of ceftobiprole against Enterococcus faecalis, including beta-lactamase-producing and vancomycin-resistant isolates. Antimicrob. Agents Chemother. 51:2043-2047. (Pubitemid 46903092)
3. Azoulay-Dupuis E, et al. 2004. Efficacy of BAL5788, a prodrug of cephalosporin BAL9141, in a mouse model of acute pneumococcal pneumonia. Antimicrob. Agents Chemother. 48:1105-1111. (Pubitemid 38405461)
4. Berenger R, Bourdon N, Auzou M, Leclercq R, Cattoir V. 2011. In vitro activity of new antimicrobial agents against glycopeptide-resistant Enterococcus faecium clinical isolates from France between 2006 and 2008. Med. Mal. Infect. 41:405-409.
5. Blango MG, Mulvey MA. 2010. Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrob. Agents Chemother. 54:1855-1863.
6. Bourgogne A, Hilsenbeck SG, Dunny GM, Murray BE. 2006. Comparison of OG1RF and an isogenic fsrB deletion mutant by transcriptional analysis: the Fsr system of Enterococcus faecalis is more than the activator of gelatinase and serine protease. J. Bacteriol. 188:2875-2884.
7. Chambers HF. 2005. Evaluation of ceftobiprole in a rabbit model of aortic valve endocarditis due to methicillin-resistant and vancomycinintermediate Staphylococcus aureus. Antimicrob. Agents Chemother. 49:884-888. (Pubitemid 40327700)
8. CLSI. 2005. Performance standard for antimicrobial susceptibility testing; 15th informational supplement, M100-S15. Clinical and Laboratory Standards Institute, Wayne, Pa.
9. Deshpande LM, Jones RN. 2003. Bactericidal activity and synergy studies of BAL9141, a novel pyrrolidinone-3-ylidenemethyl cephem, tested against streptococci, enterococci and methicillin-resistant staphylococci. Clin. Microbiol. Infect. 9:1120-1124. (Pubitemid 37428051)
10. Entenza JM, Hohl P, Heinze-Krauss I, Glauser MP, Moreillon P. 2002. BAL9141, a novel extended-spectrum cephalosporin active against methicillin-resistant Staphylococcus aureus in treatment of experimental endocarditis. Antimicrob. Agents Chemother. 46:171-177. (Pubitemid 34031620)
11. Entenza JM, et al. 2011. In vivo synergism of ceftobiprole and vancomycin against experimental endocarditis due to vancomycinintermediate Staphylococcus aureus. Antimicrob. Agents Chemother. 55:3977-3984.
12. Fernandez J, et al. 2010. In vivo activity of ceftobiprole in murine skin infections due to Staphylococcus aureus and Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 54:116-125.
13. Guiton PS, Hung CS, Hancock LE, Caparon MG, Hultgren SJ. 2010. Enterococcal biofilm formation and virulence in an optimized murine model of foreign body-associated urinary tract infections. Infect. Immun. 78:4166-4175.
14. Hebeisen P, et al. 2001. In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci. Antimicrob. Agents Chemother. 45:825-836. (Pubitemid 32182033)
15. Henry X, Amoroso A, Coyette J, Joris B. 2010. Interaction of ceftobiprole with the low-affinity PBP 5 of Enterococcus faecium. Antimicrob. Agents Chemother. 54:953-955.
16. Hidron AI, et al. 2008. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect. Control Hosp. Epidemiol. 29:996-1011.
17. Hindes RG, et al. 1989. Treatment of experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin. Antimicrob. Agents Chemother. 33:1019-1022. (Pubitemid 19168658)
18. Hooton TM, Stamm WE. 1997. Diagnosis and treatment of uncomplicated urinary tract infection. Infect. Dis. Clin. North Am. 11:551-581. (Pubitemid 27445472)
19. Hung CS, Dodson KW, Hultgren SJ. 2009. A murine model of urinary tract infection. Nat. Protoc. 4:1230-1243.
20. Huycke MM, Sahm DF, Gilmore MS. 1998. Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future. Emerg. Infect. Dis. 4:239-249. (Pubitemid 28311210)
21. Hvidberg H, et al. 2000. Development of a long-term ascending urinary tract infection mouse model for antibiotic treatment studies. Antimicrob. Agents Chemother. 44:156-163. (Pubitemid 30010687)
22. Kau AL, et al. 2005. Enterococcus faecalis tropism for the kidneys in the urinary tract of C57BL/6J mice. Infect. Immun. 73:2461-2468. (Pubitemid 40470849)
23. Kemp KD, Singh KV, Nallapareddy SR, Murray BE. 2007. Relative contributions of Enterococcus faecalis OG1RF sortase-encoding genes, srtA and bps (srtC), to biofilm formation and a murine model of urinary tract infection. Infect. Immun. 75:5399-5404. (Pubitemid 350033628)
24. Lister PD, Sanders CC. 1995. Comparison of ampicillin-sulbactam regimens simulating 1.5-and 3.0-gram doses to humans in treatment of Escherichia coli bacteremia in mice. Antimicrob. Agents Chemother. 39:930-936.
25. Murray BE, Mederski-Samaroj B. 1983. Transferable beta-lactamase. A new mechanism for in vitro penicillin resistance in Streptococcus faecalis. J. Clin. Invest. 72:1168-1171. (Pubitemid 14212635)
26. Murray BE, et al. 1993. Generation of restriction map of Enterococcus faecalis OG1 and investigation of growth requirements and regions encoding biosynthetic function. J. Bacteriol. 175:5216-5223. (Pubitemid 23232585)
27. Nannini EC, et al. 2010. Determination of an inoculum effect with various cephalosporins among clinical isolates of methicillinsusceptible Staphylococcus aureus. Antimicrob. Agents Chemother. 54:2206-2208.
28. Queenan AM, Shang W, Kania M, Page MG, Bush K. 2007. Interactions of ceftobiprole with beta-lactamases from molecular classes A to D. Antimicrob. Agents Chemother. 51:3089-3095. (Pubitemid 350067513)
29. Reed LJ, Muench H. 1938. A simple method of estimating fifty percent end points. Am. J. Hyg. 27:493-497.
30. Reyes N, et al. 2005. Efficacy of telavancin (TD-6424), a rapidly bactericidal lipoglycopeptide with multiple mechanisms of action, in a murine model of pneumonia induced by methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 49:4344-4346. (Pubitemid 41400983)
31. Schmitt-Hoffmann A, et al. 2004. Multiple-dose pharmacokinetics and safety of a novel broad-spectrum cephalosporin (BAL5788) in healthy volunteers. Antimicrob. Agents Chemother. 48:2576-2580. (Pubitemid 38823427)
32. Singh KV, Lewis RJ, Murray BE. 2009. Importance of the epa locus of Enterococcus faecalis OG1RF in a mouse model of ascending urinary tract infection. J. Infect. Dis. 200:417-420.
33. Singh KV, Nallapareddy SR, Murray BE. 2007. Importance of the ebp (endocarditis-and biofilm-associated pilus) locus in the pathogenesis of Enterococcus faecalis ascending urinary tract infection. J. Infect. Dis. 195:1671-1677. (Pubitemid 46799225)
34. Stickler DJ. 2008. Bacterial biofilms in patients with indwelling urinary catheters. Nat. Clin. Pract. Urol. 5:598-608.
35. Zscheck KK, Murray BE. 1991. Nucleotide sequence of the betalactamase gene from Enterococcus faecalis HH22 and its similarity to staphylococcal beta-lactamase genes. Antimicrob. Agents Chemother. 35:1736-1740.